Iranian consensus on use of vitamin D in patients with multiple sclerosis

Accumulating evidences from experimental, epidemiologic and clinical studies support the potential linkage between poor vitamin D status and the risk of developing Multiple Sclerosis (MS), as well as, an adverse disease course. However, the results of the trials on the clinical outcomes of vitamin D supplementation in MS patients are less consistent which brought many discrepancies in routine practice.Iranian consensus on use of vitamin D in patients with multiple sclerosis.Jahromi SRSahraian MA , Togha MSedighi BShayegannejad VNickseresht ANafissi SMohebbi NMajdinasab NForoughipour M,Etemadifar MMoghadam NB Ayramlou HAshtari FAlaie S. Their findings were published online in : BMC Neurol. 2016 May 21;16(1):76. doi: 10.1186/s12883-016-0586-3.Article  download : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4875642/

Tags: